Lu Song

752 total citations · 1 hit paper
11 papers, 578 citations indexed

About

Lu Song is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Lu Song has authored 11 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Lu Song's work include Inflammatory Bowel Disease (5 papers), Cancer-related molecular mechanisms research (2 papers) and Immune Cell Function and Interaction (2 papers). Lu Song is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Cancer-related molecular mechanisms research (2 papers) and Immune Cell Function and Interaction (2 papers). Lu Song collaborates with scholars based in China, South Sudan and Hong Kong. Lu Song's co-authors include Xiaobing Wang, Sha Huang, Wei Wang, Bing Xia, Liping Chen, Ge Wang, Rui Zhou, Bing Xia, Fengming Yi and Feng Zhou and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Medicine.

In The Last Decade

Lu Song

11 papers receiving 573 citations

Hit Papers

Increased Proportions of Bifidobacterium and the Lactobac... 2013 2026 2017 2021 2013 100 200 300

Peers

Lu Song
Réka Szigeti United States
Paul Flanagan United Kingdom
O. Schneider Germany
Joseph Mercado Philippines
JO Lindsay United Kingdom
Aaron Ver Heul United States
Dulari Jayawardena United States
Mansour Mohamadzadeh United States
Réka Szigeti United States
Lu Song
Citations per year, relative to Lu Song Lu Song (= 1×) peers Réka Szigeti

Countries citing papers authored by Lu Song

Since Specialization
Citations

This map shows the geographic impact of Lu Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Song more than expected).

Fields of papers citing papers by Lu Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Song. The network helps show where Lu Song may publish in the future.

Co-authorship network of co-authors of Lu Song

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Song. A scholar is included among the top collaborators of Lu Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Song. Lu Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Song, Lu, et al.. (2021). LncRNA CASC2 Alleviates Sepsis-induced Acute Lung Injury by Regulating the miR-152-3p/PDK4 Axis. Immunological Investigations. 51(5). 1257–1271. 16 indexed citations
2.
Xue, Yan, et al.. (2019). DL-3-n-butylphthalide attenuates lipopolysaccharide-induced acute lung injury via SIRT1-dependent and -independent regulation of Nrf2. International Immunopharmacology. 74. 105658–105658. 21 indexed citations
3.
Liu, Zhenguo, et al.. (2016). Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats. Drug Design Development and Therapy. 10. 547–547. 7 indexed citations
4.
Wang, Xiaobing, Ting Wu, Feng Zhou, et al.. (2015). IL12p40 Regulates Functional Development of Human CD4+ T Cells. Medicine. 94(10). e613–e613. 11 indexed citations
5.
Wang, Xiaobing, Ge Wang, Jinghui Wang, et al.. (2014). Coagulation state in patients with Crohn’s disease. European Journal of Gastroenterology & Hepatology. 26(9). 955–963. 4 indexed citations
6.
Zhou, Feng, Jinsheng Tao, Lu Song, et al.. (2014). Exome Sequencing Identifies DLG1 as a Novel Gene for Potential Susceptibility to Crohn's Disease in a Chinese Family Study. PLoS ONE. 9(6). e99807–e99807. 17 indexed citations
7.
Zhu, Siying, Xiaobing Wang, Qiao Yu, et al.. (2014). CCL25/CCR9 Interactions Regulate the Function of iNKT Cells in Oxazolone-Induced Colitis in Mice. PLoS ONE. 9(6). e100167–e100167. 13 indexed citations
8.
Yi, Fengming, Jie Zhao, Sha Huang, et al.. (2013). The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China. Virology Journal. 10(1). 43–43. 26 indexed citations
9.
Zhang, Yi, Hao Hu, Lu Song, et al.. (2013). Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation. Toxicology Letters. 222(1). 1–9. 32 indexed citations
10.
Wang, Wei, Liping Chen, Rui Zhou, et al.. (2013). Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease. Journal of Clinical Microbiology. 52(2). 398–406. 396 indexed citations breakdown →
11.
Song, Lu, Rui Zhou, Sha Huang, et al.. (2013). High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel Disease. Mediators of Inflammation. 2013. 1–10. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026